<p>Compositions and methods for making and using therapeutic formulations of measles virus antigens with a Proteosome-based adjuvant are provided. The measles virus antigens may be derived from a variety of sources, such as from recombinant production or from a split antigen preparation. The measles vaccine formulations may be used, for example, in methods for treating or preventing a measles virus infection and eliciting a protective immune response.</p>
申请公布号
WO2005027964(A1)
申请公布日期
2005.03.31
申请号
WO2004US30361
申请日期
2004.09.15
申请人
ID BIOMEDICAL CORPORATION OF QUEBEC;MCGILL UNIVERSITY;ID BIOMEDICAL CORPORATION OF WASHINGTON;BURT, DAVID, S.;WARD, BRIAN, J.;CHABOT, SOPHIE